These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5871030)

  • 21. [Influence of increasing doses of glutethimide (Doriden) on pregnancy and fetal development in the rabbit].
    TUCHMANN-DUPLESSIS H; MERCIER-PAROT L
    C R Seances Soc Biol Fil; 1963; 157():5-8. PubMed ID: 13994674
    [No Abstract]   [Full Text] [Related]  

  • 22. [Glutethimide derivatives: inhibitors of steroid biosynthesis as tumor chemotherapy].
    Tschiersch B; Schwabe K
    Pharmazie; 1988 May; 43(5):352-4. PubMed ID: 3051056
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on hormonal regulation of the growth of the craniofacial skeleton: III. Effects of 24,25 (OH)2D3 on cartilage growth in the mandibular condyle of suckling mice.
    Mirsky N; Silbermann M
    J Craniofac Genet Dev Biol; 1984; 4(4):303-20. PubMed ID: 6335149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of thalidomide on human embryonic tissues.
    Lash JW; Saxén L
    Nature; 1971 Aug; 232(5313):634-5. PubMed ID: 4106061
    [No Abstract]   [Full Text] [Related]  

  • 25. RF VALUES OF SOME GLUTARIMIDES.
    DAVIES D; NICHOLLS PJ
    J Chromatogr; 1965 Feb; 17():416-9. PubMed ID: 14304232
    [No Abstract]   [Full Text] [Related]  

  • 26. Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis.
    Du GJ; Lin HH; Xu QT; Wang MW
    Vascul Pharmacol; 2005 Aug; 43(2):112-9. PubMed ID: 15982930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nuclear magnetic resonance spectra of some glutarimide derivatives].
    Defay N; Dorlet C
    J Pharm Belg; 1972; 26(3):335-45. PubMed ID: 5048356
    [No Abstract]   [Full Text] [Related]  

  • 28. Suppression of urokinase receptor expression by thalidomide is associated with inhibition of nuclear factor kappaB activation and subsequently suppressed ovarian cancer dissemination.
    Kobayashi H; Yagyu T; Kondo T; Kurita N; Inagaki K; Haruta S; Kawaguchi R; Kitanaka T; Sakamoto Y; Yamada Y; Kanayama N; Terao T
    Cancer Res; 2005 Nov; 65(22):10464-71. PubMed ID: 16288038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells.
    Komorowski J; Jerczyńska H; Siejka A; Barańska P; Ławnicka H; Pawłowska Z; Stepień H
    Life Sci; 2006 Apr; 78(22):2558-63. PubMed ID: 16310808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalidomide influences the function of macrophages and increases the survival of Plasmodium berghei-infected CBA mice.
    Muniz-Junqueira MI; Silva FO; de Paula-Júnior MR; Tosta CE
    Acta Trop; 2005 May; 94(2):128-38. PubMed ID: 15817259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the pharmacology of morpholino-aklyl derivatives of glutethimides.
    Petkov V
    C R Acad Bulg Sci; 1968 Feb; 21(2):171-4. PubMed ID: 5699425
    [No Abstract]   [Full Text] [Related]  

  • 32. Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation.
    Noman AS; Koide N; Khuda II; Dagvadorj J; Tumurkhuu G; Naiki Y; Komatsu T; Yoshida T; Yokochi T
    Biochem Biophys Res Commun; 2008 Oct; 374(4):683-7. PubMed ID: 18662673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn.
    Israyelyan A; Shannon EJ; Baghian A; Kearney MT; Kousoulas KG
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1201-10. PubMed ID: 19308409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma.
    Zhang S; Li M; Gu Y; Liu Z; Xu S; Cui Y; Sun B
    J Exp Clin Cancer Res; 2008 Nov; 27(1):60. PubMed ID: 18983651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalidomide inhibits activation of caspase-1.
    Keller M; Sollberger G; Beer HD
    J Immunol; 2009 Nov; 183(9):5593-9. PubMed ID: 19843943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thalidomide inhibits early atherogenesis in apoE-deficient mice.
    Chew M; Zhou J; Daugherty A; Eriksson T; Ellermann-Eriksen S; Hansen PR; Falk E
    APMIS Suppl; 2003; (109):113-6. PubMed ID: 12874961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modification of the convulsant threshold of bemegride by psychotropic drugs].
    Nakajima H; Granjean JL; Thuillier J
    Encephale; 1965; 54(5):470-3. PubMed ID: 5863483
    [No Abstract]   [Full Text] [Related]  

  • 38. Thalidomide treatment reduces colon injury induced by experimental colitis.
    Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
    Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma.
    Kaicker S; McCrudden KW; Beck L; New T; Huang J; Frischer JS; Serur A; Kadenhe-Chiweshe A; Yokoi A; Kandel JJ; Yamashiro DJ
    Int J Oncol; 2003 Dec; 23(6):1651-5. PubMed ID: 14612937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of severe barbiturate poisoning by beta-ethyl-beta-methyl-glutarimide (megimide-bemegride)].
    ALAMEL P; GEOFFROY H
    Maroc Med; 1963 Feb; 42():148-9. PubMed ID: 14011627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.